A variant of the SARS-CoV-2 virus, known as EG.5.1, has been found to be able to escape neutralizing antibodies better than other strains, according to a study published in The Lancet Infectious Diseases journal. However, researchers have stated that this increase in antibody escape is only moderate, and does not completely undermine the immunity established through vaccination or prior infection.